Detalhe da pesquisa
1.
Real-World Outcomes Among Older Mexican Women with Breast Cancer Treated with Neoadjuvant Chemotherapy.
Oncologist
; 25(12): 1023-1031, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275801
2.
Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis.
Clin Transl Sci
; 15(10): 2403-2436, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35892315
3.
Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review.
PLoS One
; 16(4): e0250057, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33861773
4.
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
PLoS One
; 15(4): e0231953, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32353087
5.
Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer.
Oncotarget
; 9(6): 6872-6882, 2018 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29467936
6.
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.
J Cancer
; 9(8): 1437-1447, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29721054
7.
Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
PLoS One
; 12(9): e0185231, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28957377